This educational activity is directed toward dermatologists, nurse practitioners, physician assistants, nurses, and other health care professionals who are involved in the treatment and management of HS. Primary care providers and women’s health professionals who may be involved in first-line diagnosis of HS are also invited to participate.
The clinical and psychosocial burdens of hidradenitis suppurativa (HS) are unequally distributed across various patient populations. The impact of these burdens is exacerbated by barriers to optimal care, which can lead to diagnostic delay and patient distrust of the medical system. An overview of clinical approaches to mitigate difficulties experienced by patients with HS in special populations will be presented in a multimedia format, including a series of video interviews with expert thought leaders integrated into text-based elements.